2002
DOI: 10.1034/j.1600-6143.2002.21011.x
|View full text |Cite
|
Sign up to set email alerts
|

Use of EBV PCR for the Diagnosis and Monitoring of Post-Transplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Patients

Abstract: Epstein-Barr virus (EBV) is known to be involved in

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
41
2
1

Year Published

2003
2003
2015
2015

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 70 publications
(47 citation statements)
references
References 29 publications
3
41
2
1
Order By: Relevance
“…With potential risks of CT contrast dye and expense of the procedures, there is a need for a simple blood-based monitoring test. Epstein-Barr virus PCR of peripheral blood lymphocytes has been shown to be an effective diagnostic and monitoring tool in some patients (9). However the availability and expense of EBV PCR in many centers hinders its widespread use.…”
Section: Discussionmentioning
confidence: 99%
“…With potential risks of CT contrast dye and expense of the procedures, there is a need for a simple blood-based monitoring test. Epstein-Barr virus PCR of peripheral blood lymphocytes has been shown to be an effective diagnostic and monitoring tool in some patients (9). However the availability and expense of EBV PCR in many centers hinders its widespread use.…”
Section: Discussionmentioning
confidence: 99%
“…Despite the consensus that PTLD patients have a significantly higher EBV-DNA load compared with healthy EBV-seropositive donors or non-PTLD transplant recipients, it is still unclear which threshold values are predictive for PTLD. Many different threshold values have been reported, all with different sensitivity (60-100%) and specificity (71-100%) (Lee TC et al, 2005;Rowe DT et al, 2001;Tsai DE et al, 2002). Another limitation of EBV-DNA load monitoring may be the observation that PTLD developing late after transplantation is not necessarily associated with EBV (negative staining for EBV in the tumour), and may therefore develop without a concomitant rise in EBV-DNA load.…”
Section: Ebv Dna Load Monitoring After Transplantationmentioning
confidence: 99%
“…Despite the consensus that PTLD patients have a significantly higher EBV-DNA load compared with healthy EBV-seropositive donors or non-PTLD transplant recipients, it is still unclear which threshold values are predictive for PTLD. Many different threshold values have been reported, all with different sensitivity (60-100%) and specificity (71-100%) (Lee et al, 2005;Rowe et al, 2001;Tsai et al, 2002). Another limitation of EBV-DNA load monitoring may be the observation that PTLD developing late after transplantation is not Fig.…”
Section: Ebv Dna Load Monitoring After Transplantationmentioning
confidence: 99%